Shao-Lee Lin Insider Trading $HZNP Horizon Therapeutics Public Ltd Co

FREE EMAIL WATCHDOG

Get free email notifications about insider trading for Shao-Lee Lin.

Your email is safe with us.
The service is free and you can unsubscribe at any time.

General | Insider Transactions | Monthly Overview

Get the latest insider transactions of Shao-Lee Lin. Shao-Lee Lin is EVP, Head of R&D and CSO in Horizon Pharma plc ($HZNP) and Director in Principia Biopharma Inc. ($PRNB).

Shao-Lee Lin in Horizon Therapeutics Public Ltd Co

Trading Symbol: HZNP
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of Shao-Lee Lin: EVP, Head of R&D and CSO
Holdings: 112,384 shares
Current Value: $1,894,794
Latest Transaction: Jan 23 2020
$HZNP Market Capitalization: $2.68B
$HZNP Previous Close: $16.86

Last 4 weeks trend: HOLD
Last 3 months trend: HOLD

Latest Insider Trading Transactions of Shao-Lee Lin in Horizon Therapeutics Public Ltd Co

	1 Week	2 Weeks	1 Month	3 Months	6 Months	1 Year	2 Years
No. of Purchases	0	0	0	0	0	0	0
Value of Purchases ($)	0	0	0	0	0	0	0
No. of Sales	0	0	0	0	0	0	0
Value of Sales ($)	0	0	0	0	0	0	0

Sentiment: All, HZNP, PRNB

Page: 1

Date	Ticker	Company	Owner	Relationship	Transaction	Code	Cost ($)	Shares	Transaction Value ($)	Total Shares	% Holdings
Jan 23 2020	HZNP	Horizon Therapeuti ...	Lin Shao-Lee	EVP, Head of R&D an ...	Option Exercise	A	0.00	12,262	0	12,262
Jan 23 2020	HZNP	Horizon Therapeuti ...	Lin Shao-Lee	EVP, Head of R&D an ...	Payment of Exercise	F	38.25	2,716	103,887	109,668	112.4 K to 109.7 K (-2.42 %)
Jan 23 2020	HZNP	Horizon Therapeuti ...	Lin Shao-Lee	EVP, Head of R&D an ...	Grant	A	0.00	6,129	0	112,384	106.3 K to 112.4 K (+5.77 %)
Jan 07 2020	HZNP	Horizon Therapeuti ...	Lin Shao-Lee	EVP, Head of R&D an ...	Option Exercise	M	0.00	32,362	0	32,363
Jan 07 2020	HZNP	Horizon Therapeuti ...	Lin Shao-Lee	EVP, Head of R&D an ...	Option Exercise	M	0.00	17,982	0	35,966
Jan 07 2020	HZNP	Horizon Therapeuti ...	Lin Shao-Lee	EVP, Head of R&D an ...	Option Exercise	M	0.00	17,892	0	35,784
Jan 07 2020	HZNP	Horizon Therapeuti ...	Lin Shao-Lee	EVP, Head of R&D an ...	Option Exercise	A	0.00	36,284	0	36,284
Jan 07 2020	HZNP	Horizon Therapeuti ...	Lin Shao-Lee	EVP, Head of R&D an ...	Payment of Exercise	F	36.10	38,100	1,375,410	106,255	144.4 K to 106.3 K (-26.39 %)
Jan 07 2020	HZNP	Horizon Therapeuti ...	Lin Shao-Lee	EVP, Head of R&D an ...	Grant	A	0.00	35,652	0	144,355	108.7 K to 144.4 K (+32.80 %)
Jan 07 2020	HZNP	Horizon Therapeuti ...	Lin Shao-Lee	EVP, Head of R&D an ...	Buy	M	0.00	50,344	0	108,703	58.4 K to 108.7 K (+86.27 %)
Jan 07 2020	HZNP	Horizon Therapeuti ...	Lin Shao-Lee	EVP, Head of R&D an ...	Payment of Exercise	F	36.10	8,113	292,879	58,359	66.5 K to 58.4 K (-12.21 %)
Jan 07 2020	HZNP	Horizon Therapeuti ...	Lin Shao-Lee	EVP, Head of R&D an ...	Buy	M	0.00	17,892	0	66,472	48.6 K to 66.5 K (+36.83 %)
Feb 22 2019	HZNP	Horizon Pharma plc	Lin Shao-Lee	EVP, Head of R&D an ...	Payment of Exercise	F	21.54	15,795	340,224	47,531	63.3 K to 47.5 K (-24.94 %)
Feb 22 2019	HZNP	Horizon Pharma plc	Lin Shao-Lee	EVP, Head of R&D an ...	Grant	A	0.00	35,652	0	63,326	27.7 K to 63.3 K (+128.83 %)
Jan 08 2019	HZNP	Horizon Pharma plc	Lin Shao-Lee	EVP, Head of R&D an ...	Option Exercise	M	0.00	32,362	0	64,725
Jan 08 2019	HZNP	Horizon Pharma plc	Lin Shao-Lee	EVP, Head of R&D an ...	Option Exercise	M	0.00	32,362	0	64,725
Jan 08 2019	HZNP	Horizon Pharma plc	Lin Shao-Lee	EVP, Head of R&D an ...	Option Exercise	A	0.00	53,948	0	53,948
Jan 08 2019	HZNP	Horizon Pharma plc	Lin Shao-Lee	EVP, Head of R&D an ...	Option Exercise	A	0.00	53,948	0	53,948
Jan 08 2019	HZNP	Horizon Pharma plc	Lin Shao-Lee	EVP, Head of R&D an ...	Option Exercise	M	0.00	17,891	0	53,676
Jan 08 2019	HZNP	Horizon Pharma plc	Lin Shao-Lee	EVP, Head of R&D an ...	Option Exercise	M	0.00	17,891	0	53,676
Jan 08 2019	HZNP	Horizon Pharma plc	Lin Shao-Lee	EVP, Head of R&D an ...	Payment of Exercise	F	20.39	14,337	292,331	27,674	42 K to 27.7 K (-34.13 %)
Jan 08 2019	HZNP	Horizon Pharma plc	Lin Shao-Lee	EVP, Head of R&D an ...	Payment of Exercise	F	20.39	14,337	292,331	27,674	42 K to 27.7 K (-34.13 %)
Jan 08 2019	HZNP	Horizon Pharma plc	Lin Shao-Lee	EVP, Head of R&D an ...	Buy	M	0.00	32,362	0	42,011	9.6 K to 42 K (+335.39 %)
Jan 08 2019	HZNP	Horizon Pharma plc	Lin Shao-Lee	EVP, Head of R&D an ...	Buy	M	0.00	32,362	0	42,011	9.6 K to 42 K (+335.39 %)
Jan 08 2019	HZNP	Horizon Pharma plc	Lin Shao-Lee	EVP, Head of R&D an ...	Payment of Exercise	F	20.39	8,242	168,054	9,649	17.9 K to 9.6 K (-46.07 %)
Jan 08 2019	HZNP	Horizon Pharma plc	Lin Shao-Lee	EVP, Head of R&D an ...	Payment of Exercise	F	20.39	8,242	168,054	9,649	17.9 K to 9.6 K (-46.07 %)
Jan 08 2019	HZNP	Horizon Pharma plc	Lin Shao-Lee	EVP, Head of R&D an ...	Buy	M	0.00	17,891	0	17,891	0 to 17.9 K
Jan 08 2019	HZNP	Horizon Pharma plc	Lin Shao-Lee	EVP, Head of R&D an ...	Buy	M	0.00	17,891	0	17,891	0 to 17.9 K
May 07 2018	HZNP	Horizon Pharma plc	Lin Shao-Lee	EVP, Head of R&D an ...	Option Exercise	A	0.00	97,087	0	97,087
May 07 2018	HZNP	Horizon Pharma plc	Lin Shao-Lee	EVP, Head of R&D an ...	Option Exercise	A	0.00	97,087	0	97,087
Jan 05 2018	HZNP	Horizon Pharma plc	Lin Shao-Lee	EVP, Head of R&D an ...	Option Exercise	A	0.00	71,567	0	71,567
Jan 05 2018	HZNP	Horizon Pharma plc	Lin Shao-Lee	EVP, Head of R&D an ...	Option Exercise	A	15.37	146,685	2,254,548	146,685

Page: 1